RYAHF (RYAH Group) Debt-to-Asset : 1.72 (As of Sep. 2022)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is RYAH Group Debt-to-Asset?

RYAH Group RYAHF Debt-to-Asset is 1.72 as of Sep. 2022.

RYAH Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2022 was $0.02 Mil. RYAH Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2022 was $0.20 Mil. RYAH Group's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Sep. 2022 was $0.13 Mil. RYAH Group's debt to asset for the quarter that ended in Sep. 2022 was 1.72.


RYAH Group  (OTCPK:RYAHF) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


RYAH Group Debt-to-Asset Related Terms


RYAH Group Debt-to-Asset Historical Data

* Premium members only.

The historical data trend for RYAH Group's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RYAH Group Debt-to-Asset Chart

RYAH Group Annual Data
Trend Dec20 Dec21
Debt-to-Asset
3.14 0.04

RYAH Group Quarterly Data
Feb20 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Debt-to-Asset Get a 7-Day Free Trial 0.45 0.04 0.13 0.84 1.72

RYAHF vs CERN, VEEV, CHNG: Debt-to-Asset Comparison

For the Health Information Services subindustry, RYAH Group's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RYAH Group Debt-to-Asset vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, RYAH Group's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where RYAH Group's Debt-to-Asset falls into.



RYAH Group Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

RYAH Group's Debt-to-Asset for the fiscal year that ended in Dec. 2021 is calculated as

RYAH Group's Debt-to-Asset for the quarter that ended in Sep. 2022 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Debt-to-Asset →
What does a Debt-to-Asset of 1.72 mean?
RYAH Group (RYAHF) has a Debt-to-Asset of 1.72 as of Sep. 2022. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on RYAH Group and its competitors.
Is RYAH Group's Debt-to-Asset too high?
RYAH Group's current Debt-to-Asset is 1.72.
How does RYAH Group's Debt-to-Asset compare to CERN and VEEV?
RYAH Group's Debt-to-Asset of 1.72 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Asset for a Healthcare Providers & Services company?
A good Debt-to-Asset depends on the Healthcare Providers & Services industry context. However, Debt-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Asset mean?
A high Debt-to-Asset can signal that a stock is expensive relative to its fundamentals. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on RYAH Group and its competitors. RYAH Group's current Debt-to-Asset is 1.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RYAH Group stock overvalued right now?
RYAH Group (RYAHF) has a current Debt-to-Asset of 1.72. The current Debt-to-Asset is 1.72. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Asset calculated?
Debt-to-Asset is calculated from a company's financial statements. For RYAH Group (RYAHF), the current Debt-to-Asset is 1.72 as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

RYAH Group Business Description

Address 68 34TH STREET, SUITE B421, BROOKLYN, NY, USA, 11232
RYAH Group Inc is a data technology company in plant-based medicine. Its Artificial Intelligence platform aggregates and correlates HIPAA-compliant dosing data from seed to consumption. This helps the company to conduct predictive analyses to help doctors, researchers, and end-users create personalized dosing regimens that can accurately foresee patient outcomes. the company also provide other products which are smart inhaler system & smart patch system.